Clinical Trials Logo

Healthy Male Volunteers clinical trials

View clinical trials related to Healthy Male Volunteers.

Filter by:

NCT ID: NCT06381869 Completed - Clinical trials for Healthy Male Volunteers

Bioavailability of Pea Protein in Young and Old Volunteers

NUTRALYS
Start date: January 10, 2019
Phase: N/A
Study type: Interventional

The aim of this study done in healthy, non-malnourished young and elderly subjects, is to measure the bioavailability of protein intake and the variation of metabolic markers following consumption of pea protein " NUTRALYS ® S85 plus" or a reference protein brought in water either alone or at the end of a standardized meal.

NCT ID: NCT06159101 Recruiting - Clinical trials for Healthy Male Volunteers

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects

Start date: November 28, 2023
Phase: Phase 1
Study type: Interventional

Phase I Study to Compare the Pharmacokinetic Characteristics, Safety, Tolerability, and Immunogenicity (Randomized, Double-blind, Parallel Controlled) of HLX13 with YERVOY® Injection in Healthy Chinese Male Subjects

NCT ID: NCT05981963 Completed - Clinical trials for Healthy Male Volunteers

A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants

Start date: August 17, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the excretion pathway of orally administered [14C]-BMS-986196 and to assess the safety and tolerability of orally administered BMS-986196.

NCT ID: NCT05523687 Completed - Clinical trials for Healthy Male Volunteers

AME Study of [14C]-PC14586 in Healthy Male Participants

Start date: September 6, 2022
Phase: Phase 1
Study type: Interventional

This study will assess the PK and rates of elimination and mass balance of total radioactivity from [14C]-PC14586

NCT ID: NCT05475834 Completed - Clinical trials for Healthy Male Volunteers

Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants

Start date: July 21, 2022
Phase: Phase 1
Study type: Interventional

This is a non-randomized, open-label, single-dose, Phase I clinical study to evaluate the mass balance and biotransformation, safety and tolerability of SIM0417 in healthy Chinese adult male subjects following a single oral administration of SIM0417 in combination with ritonavir.

NCT ID: NCT05105425 Completed - Clinical trials for Healthy Male Volunteers

The Effects of Daily Supplementation of Nutriose® on the Fecal Microbiota in Volunteers.

NUTRIBIOTE
Start date: July 19, 2021
Phase: N/A
Study type: Interventional

The effects of daily supplementation of the NUTRIOSE® on the fecal microbiota. The hypothesis of the study is that the NUTRIOSE® is able to modulate the intestinal microbiota in a positive way, compare to a placebo, in healthy volunteers.

NCT ID: NCT04810533 Completed - Clinical trials for Healthy Male Volunteers

The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers

Start date: May 13, 2020
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, single-dose phase I study to investigate the absorption, metabolism and excretion of [14C] SH-1028 in healthy Chinese male subjects. The study will be conducted into two steps:Firstly, 2 subjects are enrolled in to participate in the pilot study to grope for the collection time of plasma, urine and feces sampling post-dose. Then, the collection time of blood and excreta samples (urine and feces) from the subsequent 2-4 subjects will be adjusted according to the pilot study.

NCT ID: NCT04808648 Not yet recruiting - Clinical trials for Healthy Male Volunteers

The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028

Start date: April 6, 2021
Phase: Phase 1
Study type: Interventional

This is a phase I study to assess the drug-drug interaction of SH-1028 tablets and Itraconazole/Rifampicin tablets. The study also evaluates the pharmacokinetic and tolerability of SH-1028 tablets in healthy subjects. This study provides evidence for the designing of following clinical trial protocols.

NCT ID: NCT04633733 Active, not recruiting - Clinical trials for Healthy Male Volunteers

The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus

Start date: August 22, 2020
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the pharmacokinetic interaction between HL237 and tacrolimus in healthy male subjects.

NCT ID: NCT04534582 Completed - Clinical trials for Healthy Male Volunteers

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

Start date: November 3, 2020
Phase: Phase 1
Study type: Interventional

Part I of the study: This is a randomised, single-dose, subcutaneous injection, parallel study designed to compare the PK of HLX14 and EU-sourced Prolia® in healthy Chinese adult male subjects, and to assess the safety, tolerability, and immunogenicity of these 2 drugs. Part II of the study: This is a randomised, double-blind, four-arm, single-dose, subcutaneous injection, parallel-controlled study to evaluate the PK, PD, safety, tolerability, and immunogenicity between-group following a single subcutaneous injection of HLX14 or US, EU, CN-sourced Prolia®.